Delek US director sells 200K shares around $66-68

Q: What insider transaction did Delek US Holdings (DK) director Ezra Uzi Yemin report?

Ezra Uzi Yemin reported selling 200,000 shares of Delek US Holdings common stock on 2026-08-13. The sales were executed indirectly through Yemin Investments, LP in multiple open-market transactions at weighted average prices in the mid-$60s per share.

Q: At what prices were the Delek US Holdings (DK) shares sold in Yemin’s Form 4 filing?

The reported sales occurred at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share. Each figure reflects a weighted average sale price over multiple trades within specific high-low price ranges disclosed in the footnotes.

Q: Was the Delek US Holdings (DK) insider sale under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions. The footnote also notes that these transactions complete this plan.

Q: How many Delek US Holdings (DK) shares does Ezra Uzi Yemin hold after the reported sales?

After the reported transactions, Ezra Uzi Yemin reports 213,717 shares of Delek US common stock held directly. The sold shares were held and sold indirectly by Yemin Investments, LP, as indicated in the ownership details.

Q: Were the Delek US Holdings (DK) insider sales executed directly or indirectly by Yemin?

The reported sales were executed indirectly through Yemin Investments, LP, which held the shares. The Form 4 identifies the ownership type as indirect, with the nature of ownership explicitly stated as “By Yemin Investments, LP.”

Delek US Holdings, Inc. director Ezra Uzi Yemin, through Yemin Investments, LP, reported open-market sales of an aggregate 200,000 shares of common stock on 2026-08-13.

Filing Impact

(Neutral)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Delek US Holdings, Inc. director Ezra Uzi Yemin, through Yemin Investments, LP, reported open-market sales of an aggregate 200,000 shares of common stock on 2026-08-13. The shares were sold in multiple trades at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share, each representing numerous transactions within disclosed price ranges, pursuant to a Rule 10b5-1 trading plan that has now been completed. Following these transactions, Yemin reports 213,717 shares of Delek US common stock held directly.

Insider Trade Summary 10b5-1

Net Seller: 200,000 shares

Net Sell 5 txns

Insider Yemin Ezra Uzi

Role Director

Sold 200,000 shs ($13.50M)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	17,566	$65.75	$1.15M
Sale	Common Stock ^{F1, F3}	38,388	$66.64	$2.56M
Sale	Common Stock ^{F1, F4}	82,224	$67.74	$5.57M
Sale	Common Stock ^{F1, F5}	61,822	$68.27	$4.22M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 247,795 shares (Indirect, By Yemin Investments, LP); Common Stock — 213,717 shares (Direct)

Footnotes (5)

F1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). These transactions complete this plan.
F2. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $65.15 per share to a high sale price of $66.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F3. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $66.15 per share to a high sale price of $67.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F4. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $67.15 per share to a high sale price of $68.14 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F5. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $68.15 per share to a high sale price of $68.45 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Key Figures

Shares sold: 200,000 shares Sale price (weighted average block 1): $65.75 per share Sale price (weighted average block 2): $66.64 per share +3 more

6 metrics

Shares sold 200,000 shares Total common shares sold on 2026-08-13 across four transactions

Sale price (weighted average block 1) $65.75 per share Weighted average sale price for 17,566 shares on 2026-08-13

Sale price (weighted average block 2) $66.64 per share Weighted average sale price for 38,388 shares on 2026-08-13

Sale price (weighted average block 3) $67.74 per share Weighted average sale price for 82,224 shares on 2026-08-13

Sale price (weighted average block 4) $68.27 per share Weighted average sale price for 61,822 shares on 2026-08-13

Direct holdings after transactions 213,717 shares Directly held Delek US common stock reported after 2026-08-13

Key Terms

Rule 10b5-1, affirmative defense conditions, weighted average sale price

3 terms

Rule 10b5-1 regulatory

"This transaction was made pursuant to a 10b5-1 plan and is intended"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

affirmative defense conditions regulatory

"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)"

weighted average sale price financial

"This price reflects the weighted average sale price of multiple transactions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Delek US Holdings (DK) director Ezra Uzi Yemin report?

Ezra Uzi Yemin reported selling 200,000 shares of Delek US Holdings common stock on 2026-08-13. The sales were executed indirectly through Yemin Investments, LP in multiple open-market transactions at weighted average prices in the mid-$60s per share.

At what prices were the Delek US Holdings (DK) shares sold in Yemin’s Form 4 filing?

The reported sales occurred at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share. Each figure reflects a weighted average sale price over multiple trades within specific high-low price ranges disclosed in the footnotes.

Was the Delek US Holdings (DK) insider sale under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions. The footnote also notes that these transactions complete this plan.

How many Delek US Holdings (DK) shares does Ezra Uzi Yemin hold after the reported sales?

After the reported transactions, Ezra Uzi Yemin reports 213,717 shares of Delek US common stock held directly. The sold shares were held and sold indirectly by Yemin Investments, LP, as indicated in the ownership details.

Were the Delek US Holdings (DK) insider sales executed directly or indirectly by Yemin?

The reported sales were executed indirectly through Yemin Investments, LP, which held the shares. The Form 4 identifies the ownership type as indirect, with the nature of ownership explicitly stated as “By Yemin Investments, LP.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/17/2026 - 08:08 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yemin Ezra Uzi

(Last)

(First)

(Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD

TENNESSEE

37027

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/13/2026		S		17,566⁽¹⁾	D	$65.75⁽²⁾	430,229	I	By Yemin Investments, LP
Common Stock	08/13/2026		S		38,388⁽¹⁾	D	$66.64⁽³⁾	391,841	I	By Yemin Investments, LP
Common Stock	08/13/2026		S		82,224⁽¹⁾	D	$67.74⁽⁴⁾	309,617	I	By Yemin Investments, LP
Common Stock	08/13/2026		S		61,822⁽¹⁾	D	$68.27⁽⁵⁾	247,795	I	By Yemin Investments, LP
Common Stock								213,717	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). These transactions complete this plan.

2. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $65.15 per share to a high sale price of $66.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

3. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $66.15 per share to a high sale price of $67.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

4. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $67.15 per share to a high sale price of $68.14 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

5. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $68.15 per share to a high sale price of $68.45 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Remarks:

	/s/ Ezra Uzi Yemin	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR